You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced esophagogastric cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)

Active, not recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Afatinib and Paclitaxel
  • Los Angeles, California
  • +8 more
Mar 18, 2022

Neoadjuvant Chemotherapy and Immunotherapy for HER2(-),pMMR

Recruiting
  • Gastric Cancer
  • SOX plus Paclitaxel(albumin-bound) followed by PD-1 antibody
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Sep 12, 2022

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Esophagogastric Junction Adenocarcinoma Trial in Guangzhou (Sintilimab)

Recruiting
  • Esophagogastric Junction Adenocarcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 29, 2021

Gastric Cancer, GastroEsophageal Cancer Trial in Wuhan (Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor), Albumin-bound

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor)
  • Albumin-bound Paclitaxel
  • Wuhan, Hubei, China
    Tongji hospital of Tongji Medical College, Huazhong University o
Jan 21, 2023

CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T

Recruiting
  • CAR T-Cell Therapy
  • HEC-016(0.5×10^6 CAR-T Cells)
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen Luohu Hospital
Mar 3, 2022

Advanced Solid Tumors, Gastric Cancer, Esophagogastric Junction Cancer Trial in Beijing (IM92 CAR-T cells)

Recruiting
  • Advanced Solid Tumors
  • +3 more
  • IM92 CAR-T cells
  • Beijing, Beijing, China
    Chinese PLA GENERAL HOSPITAL
Mar 10, 2022

Esophagogastric Adenocarcinoma Trial in United States (Nintedanib)

Completed
Has Results
  • Esophagogastric Adenocarcinoma
  • Basking Ridge, New Jersey
  • +5 more
Dec 30, 2020

Stomach Tumor, Gastrointestinal Tumors, Digestive System Tumor Trial in Havana (Ocoxin-Viusid®)

Recruiting
  • Stomach Neoplasm
  • +9 more
  • Ocoxin-Viusid®
  • Havana, La Habana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Oct 20, 2021

Advanced Gastric Carcinoma Trial in Henan (camrelizumab, Apatinib Mesylate)

Recruiting
  • Advanced Gastric Carcinoma
  • Henan, China
    Henan cancer hospital/The affiliated Cancer Hospital of ZhengZho
Jun 24, 2021

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +10 more
  • Singapore, Singapore
    Novartis Investigative Site
Nov 16, 2022

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial in China (pembrolizumab, paclitaxel, docetaxel)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • +3 more
  • Hefei, Anhui, China
  • +22 more
Aug 16, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Jul 25, 2023

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

Recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Duarte, California
  • +33 more
Aug 23, 2022

Gastroesophageal Junction Adenocarcinoma, Esophagogastric Cancer Trial in Boston, Newton (FOLFOX/ nal-IRI, Paclitaxel,

Not yet recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Esophagogastric Cancer
  • FOLFOX/ nal-IRI
  • +3 more
  • Boston, Massachusetts
  • +2 more
Nov 30, 2020

Esophageal Cancer, Gastric Cancer Trial in United States (pembrolizumab, trastuzumab, capecitabine)

Active, not recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Basking Ridge, New Jersey
  • +7 more
Sep 17, 2021

Adenocarcinoma of Esophagogastric Junction Trial in Beijing (neoadjuvant Radiation plus SOX and PD-1 antibody)

Not yet recruiting
  • Adenocarcinoma of Esophagogastric Junction
  • neoadjuvant Radiation plus SOX and PD-1 antibody
  • Beijing, Beijing, China
    Peking University People's Hospital
Aug 15, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Gastric Cancer, Stomach Tumor Trial in China (XELOX or SOX, S001+XELOX or SOX)

Recruiting
  • Gastric Cancer
  • Stomach Neoplasm
  • XELOX or SOX
  • S001+XELOX or SOX
  • Fuzhou, Fujian, China
  • +8 more
Jun 18, 2021

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Esophagogastric Cancer Trial in Boston (STA-9090)

Completed
  • Esophagogastric Cancer
  • Boston, Massachusetts
  • +2 more
Jul 31, 2020

Toripalimab Combined With Anlotinib for Advanced, Relapsed, or

Recruiting
  • Gastric or Gastro-oesophageal Junction Carcinoma
  • +2 more
  • FGFR2
  • Qingdao, China
    Xiaochun Zhang
Jun 29, 2021

Adenocarcinoma of Esophagogastric Junction, Neoadjuvant Chemo, Pembrolizumab Trial in Tianjin (Pembrolizumab Injection

Recruiting
  • Adenocarcinoma of Esophagogastric Junction
  • +2 more
  • Pembrolizumab Injection [Keytruda]
  • Tianjin, Tianjin, China
    Department of minimally invasive esophageal surgery, Tianjin Med
Mar 22, 2021

Gastric Cancer, Esophageal Cancer, Adenocarcinoma Gastric Trial in Germany (Nivolumab, Ipilimumab)

Completed
  • Gastric Cancer
  • +5 more
  • Amberg, Germany
  • +34 more
May 17, 2022